Global Low Molecular Weight Heparin Market Insights and Forecast to 2028

Report ID: 1229249 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Low Molecular Weight Heparin Product Introduction
    1.2 Market by Type
        1.2.1 Global Low Molecular Weight Heparin Market Size by Type, 2017 VS 2021 VS 2028
        1.2.2 Enoxaparin
        1.2.3 Dalteparin
        1.2.4 Tinzaparin
        1.2.5 Fraxiparine
    1.3 Market by Application
        1.3.1 Global Low Molecular Weight Heparin Market Size by Application, 2017 VS 2021 VS 2028
        1.3.2 Treatment of Venous Thromboembolism
        1.3.3 Complications of Pregnancy
        1.3.4 Cardioversion of Atrial Fibrillation/Flutter
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Low Molecular Weight Heparin Production
    2.1 Global Low Molecular Weight Heparin Production Capacity (2017-2028)
    2.2 Global Low Molecular Weight Heparin Production by Region: 2017 VS 2021 VS 2028
    2.3 Global Low Molecular Weight Heparin Production by Region
        2.3.1 Global Low Molecular Weight Heparin Historic Production by Region (2017-2022)
        2.3.2 Global Low Molecular Weight Heparin Forecasted Production by Region (2023-2028)
    2.4 North America
    2.5 Europe
    2.6 China
3 Global Low Molecular Weight Heparin Sales in Volume & Value Estimates and Forecasts
    3.1 Global Low Molecular Weight Heparin Sales Estimates and Forecasts 2017-2028
    3.2 Global Low Molecular Weight Heparin Revenue Estimates and Forecasts 2017-2028
    3.3 Global Low Molecular Weight Heparin Revenue by Region: 2017 VS 2021 VS 2028
    3.4 Global Low Molecular Weight Heparin Sales by Region
        3.4.1 Global Low Molecular Weight Heparin Sales by Region (2017-2022)
        3.4.2 Global Sales Low Molecular Weight Heparin by Region (2023-2028)
    3.5 Global Low Molecular Weight Heparin Revenue by Region
        3.5.1 Global Low Molecular Weight Heparin Revenue by Region (2017-2022)
        3.5.2 Global Low Molecular Weight Heparin Revenue by Region (2023-2028)
    3.6 North America
    3.7 Europe
    3.8 Asia-Pacific
    3.9 Latin America
    3.10 Middle East & Africa
4 Competition by Manufactures
    4.1 Global Low Molecular Weight Heparin Production Capacity by Manufacturers
    4.2 Global Low Molecular Weight Heparin Sales by Manufacturers
        4.2.1 Global Low Molecular Weight Heparin Sales by Manufacturers (2017-2022)
        4.2.2 Global Low Molecular Weight Heparin Sales Market Share by Manufacturers (2017-2022)
        4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Low Molecular Weight Heparin in 2021
    4.3 Global Low Molecular Weight Heparin Revenue by Manufacturers
        4.3.1 Global Low Molecular Weight Heparin Revenue by Manufacturers (2017-2022)
        4.3.2 Global Low Molecular Weight Heparin Revenue Market Share by Manufacturers (2017-2022)
        4.3.3 Global Top 10 and Top 5 Companies by Low Molecular Weight Heparin Revenue in 2021
    4.4 Global Low Molecular Weight Heparin Sales Price by Manufacturers
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Low Molecular Weight Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        4.5.3 Global Low Molecular Weight Heparin Manufacturers Geographical Distribution
    4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
    5.1 Global Low Molecular Weight Heparin Sales by Type
        5.1.1 Global Low Molecular Weight Heparin Historical Sales by Type (2017-2022)
        5.1.2 Global Low Molecular Weight Heparin Forecasted Sales by Type (2023-2028)
        5.1.3 Global Low Molecular Weight Heparin Sales Market Share by Type (2017-2028)
    5.2 Global Low Molecular Weight Heparin Revenue by Type
        5.2.1 Global Low Molecular Weight Heparin Historical Revenue by Type (2017-2022)
        5.2.2 Global Low Molecular Weight Heparin Forecasted Revenue by Type (2023-2028)
        5.2.3 Global Low Molecular Weight Heparin Revenue Market Share by Type (2017-2028)
    5.3 Global Low Molecular Weight Heparin Price by Type
        5.3.1 Global Low Molecular Weight Heparin Price by Type (2017-2022)
        5.3.2 Global Low Molecular Weight Heparin Price Forecast by Type (2023-2028)
6 Market Size by Application
    6.1 Global Low Molecular Weight Heparin Sales by Application
        6.1.1 Global Low Molecular Weight Heparin Historical Sales by Application (2017-2022)
        6.1.2 Global Low Molecular Weight Heparin Forecasted Sales by Application (2023-2028)
        6.1.3 Global Low Molecular Weight Heparin Sales Market Share by Application (2017-2028)
    6.2 Global Low Molecular Weight Heparin Revenue by Application
        6.2.1 Global Low Molecular Weight Heparin Historical Revenue by Application (2017-2022)
        6.2.2 Global Low Molecular Weight Heparin Forecasted Revenue by Application (2023-2028)
        6.2.3 Global Low Molecular Weight Heparin Revenue Market Share by Application (2017-2028)
    6.3 Global Low Molecular Weight Heparin Price by Application
        6.3.1 Global Low Molecular Weight Heparin Price by Application (2017-2022)
        6.3.2 Global Low Molecular Weight Heparin Price Forecast by Application (2023-2028)
7 North America
    7.1 North America Low Molecular Weight Heparin Market Size by Type
        7.1.1 North America Low Molecular Weight Heparin Sales by Type (2017-2028)
        7.1.2 North America Low Molecular Weight Heparin Revenue by Type (2017-2028)
    7.2 North America Low Molecular Weight Heparin Market Size by Application
        7.2.1 North America Low Molecular Weight Heparin Sales by Application (2017-2028)
        7.2.2 North America Low Molecular Weight Heparin Revenue by Application (2017-2028)
    7.3 North America Low Molecular Weight Heparin Sales by Country
        7.3.1 North America Low Molecular Weight Heparin Sales by Country (2017-2028)
        7.3.2 North America Low Molecular Weight Heparin Revenue by Country (2017-2028)
        7.3.3 U.S.
        7.3.4 Canada
8 Europe
    8.1 Europe Low Molecular Weight Heparin Market Size by Type
        8.1.1 Europe Low Molecular Weight Heparin Sales by Type (2017-2028)
        8.1.2 Europe Low Molecular Weight Heparin Revenue by Type (2017-2028)
    8.2 Europe Low Molecular Weight Heparin Market Size by Application
        8.2.1 Europe Low Molecular Weight Heparin Sales by Application (2017-2028)
        8.2.2 Europe Low Molecular Weight Heparin Revenue by Application (2017-2028)
    8.3 Europe Low Molecular Weight Heparin Sales by Country
        8.3.1 Europe Low Molecular Weight Heparin Sales by Country (2017-2028)
        8.3.2 Europe Low Molecular Weight Heparin Revenue by Country (2017-2028)
        8.3.3 Germany
        8.3.4 France
        8.3.5 U.K.
        8.3.6 Italy
        8.3.7 Russia
9 Asia Pacific
    9.1 Asia Pacific Low Molecular Weight Heparin Market Size by Type
        9.1.1 Asia Pacific Low Molecular Weight Heparin Sales by Type (2017-2028)
        9.1.2 Asia Pacific Low Molecular Weight Heparin Revenue by Type (2017-2028)
    9.2 Asia Pacific Low Molecular Weight Heparin Market Size by Application
        9.2.1 Asia Pacific Low Molecular Weight Heparin Sales by Application (2017-2028)
        9.2.2 Asia Pacific Low Molecular Weight Heparin Revenue by Application (2017-2028)
    9.3 Asia Pacific Low Molecular Weight Heparin Sales by Region
        9.3.1 Asia Pacific Low Molecular Weight Heparin Sales by Region (2017-2028)
        9.3.2 Asia Pacific Low Molecular Weight Heparin Revenue by Region (2017-2028)
        9.3.3 China
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 India
        9.3.7 Australia
        9.3.8 China Taiwan
        9.3.9 Indonesia
        9.3.10 Thailand
        9.3.11 Malaysia
10 Latin America
    10.1 Latin America Low Molecular Weight Heparin Market Size by Type
        10.1.1 Latin America Low Molecular Weight Heparin Sales by Type (2017-2028)
        10.1.2 Latin America Low Molecular Weight Heparin Revenue by Type (2017-2028)
    10.2 Latin America Low Molecular Weight Heparin Market Size by Application
        10.2.1 Latin America Low Molecular Weight Heparin Sales by Application (2017-2028)
        10.2.2 Latin America Low Molecular Weight Heparin Revenue by Application (2017-2028)
    10.3 Latin America Low Molecular Weight Heparin Sales by Country
        10.3.1 Latin America Low Molecular Weight Heparin Sales by Country (2017-2028)
        10.3.2 Latin America Low Molecular Weight Heparin Revenue by Country (2017-2028)
        10.3.3 Mexico
        10.3.4 Brazil
        10.3.5 Argentina
11 Middle East and Africa
    11.1 Middle East and Africa Low Molecular Weight Heparin Market Size by Type
        11.1.1 Middle East and Africa Low Molecular Weight Heparin Sales by Type (2017-2028)
        11.1.2 Middle East and Africa Low Molecular Weight Heparin Revenue by Type (2017-2028)
    11.2 Middle East and Africa Low Molecular Weight Heparin Market Size by Application
        11.2.1 Middle East and Africa Low Molecular Weight Heparin Sales by Application (2017-2028)
        11.2.2 Middle East and Africa Low Molecular Weight Heparin Revenue by Application (2017-2028)
    11.3 Middle East and Africa Low Molecular Weight Heparin Sales by Country
        11.3.1 Middle East and Africa Low Molecular Weight Heparin Sales by Country (2017-2028)
        11.3.2 Middle East and Africa Low Molecular Weight Heparin Revenue by Country (2017-2028)
        11.3.3 Turkey
        11.3.4 Saudi Arabia
        11.3.5 UAE
12 Corporate Profiles
    12.1 Aspen
        12.1.1 Aspen Corporation Information
        12.1.2 Aspen Overview
        12.1.3 Aspen Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.1.4 Aspen Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 Aspen Recent Developments
    12.2 Sanofi-aventis
        12.2.1 Sanofi-aventis Corporation Information
        12.2.2 Sanofi-aventis Overview
        12.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.2.4 Sanofi-aventis Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 Sanofi-aventis Recent Developments
    12.3 Pfizer
        12.3.1 Pfizer Corporation Information
        12.3.2 Pfizer Overview
        12.3.3 Pfizer Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.3.4 Pfizer Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 Pfizer Recent Developments
    12.4 Opocrin
        12.4.1 Opocrin Corporation Information
        12.4.2 Opocrin Overview
        12.4.3 Opocrin Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.4.4 Opocrin Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 Opocrin Recent Developments
    12.5 CSBIO
        12.5.1 CSBIO Corporation Information
        12.5.2 CSBIO Overview
        12.5.3 CSBIO Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.5.4 CSBIO Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
        12.5.5 CSBIO Recent Developments
    12.6 Dongying Tiandong Pharmaceutical
        12.6.1 Dongying Tiandong Pharmaceutical Corporation Information
        12.6.2 Dongying Tiandong Pharmaceutical Overview
        12.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
        12.6.5 Dongying Tiandong Pharmaceutical Recent Developments
    12.7 Changzhou Qianhong Bio-pharma
        12.7.1 Changzhou Qianhong Bio-pharma Corporation Information
        12.7.2 Changzhou Qianhong Bio-pharma Overview
        12.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
        12.7.5 Changzhou Qianhong Bio-pharma Recent Developments
    12.8 Techdow
        12.8.1 Techdow Corporation Information
        12.8.2 Techdow Overview
        12.8.3 Techdow Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.8.4 Techdow Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
        12.8.5 Techdow Recent Developments
    12.9 Yantai Dongcheng Pharmaceutical Group
        12.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
        12.9.2 Yantai Dongcheng Pharmaceutical Group Overview
        12.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
        12.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments
13 Industry Chain and Sales Channels Analysis
    13.1 Low Molecular Weight Heparin Industry Chain Analysis
    13.2 Low Molecular Weight Heparin Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 Low Molecular Weight Heparin Production Mode & Process
    13.4 Low Molecular Weight Heparin Sales and Marketing
        13.4.1 Low Molecular Weight Heparin Sales Channels
        13.4.2 Low Molecular Weight Heparin Distributors
    13.5 Low Molecular Weight Heparin Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    14.1 Low Molecular Weight Heparin Industry Trends
    14.2 Low Molecular Weight Heparin Market Drivers
    14.3 Low Molecular Weight Heparin Market Challenges
    14.4 Low Molecular Weight Heparin Market Restraints
15 Key Finding in The Global Low Molecular Weight Heparin Study
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Low Molecular Weight Heparin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Enoxaparin
    Table 3. Major Manufacturers of Dalteparin
    Table 4. Major Manufacturers of Tinzaparin
    Table 5. Major Manufacturers of Fraxiparine
    Table 6. Global Low Molecular Weight Heparin Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
    Table 7. Global Low Molecular Weight Heparin Production by Region: 2017 VS 2021 VS 2028 (MT)
    Table 8. Global Low Molecular Weight Heparin Production by Region (2017-2022) & (MT)
    Table 9. Global Low Molecular Weight Heparin Production Market Share by Region (2017-2022)
    Table 10. Global Low Molecular Weight Heparin Production by Region (2023-2028) & (MT)
    Table 11. Global Low Molecular Weight Heparin Production Market Share by Region (2023-2028)
    Table 12. Global Low Molecular Weight Heparin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 13. Global Low Molecular Weight Heparin Sales by Region (2017-2022) & (MT)
    Table 14. Global Low Molecular Weight Heparin Sales Market Share by Region (2017-2022)
    Table 15. Global Low Molecular Weight Heparin Sales by Region (2023-2028) & (MT)
    Table 16. Global Low Molecular Weight Heparin Sales Market Share by Region (2023-2028)
    Table 17. Global Low Molecular Weight Heparin Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Low Molecular Weight Heparin Revenue Market Share by Region (2017-2022)
    Table 19. Global Low Molecular Weight Heparin Revenue by Region (2023-2028) & (US$ Million)
    Table 20. Global Low Molecular Weight Heparin Revenue Market Share by Region (2023-2028)
    Table 21. Global Low Molecular Weight Heparin Production Capacity by Manufacturers (2017-2022) & (MT)
    Table 22. Global Low Molecular Weight Heparin Capacity Market Share by Manufacturers (2017-2022)
    Table 23. Global Low Molecular Weight Heparin Sales by Manufacturers (2017-2022) & (MT)
    Table 24. Global Low Molecular Weight Heparin Sales Market Share by Manufacturers (2017-2022)
    Table 25. Global Low Molecular Weight Heparin Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 26. Global Low Molecular Weight Heparin Revenue Share by Manufacturers (2017-2022)
    Table 27. Low Molecular Weight Heparin Price by Manufacturers 2017-2022 (USD/MT)
    Table 28. Global Low Molecular Weight Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 29. Global Low Molecular Weight Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin as of 2021)
    Table 30. Low Molecular Weight Heparin Manufacturing Base Distribution and Headquarters
    Table 31. Manufacturers Low Molecular Weight Heparin Product Offered
    Table 32. Date of Manufacturers Enter into Low Molecular Weight Heparin Market
    Table 33. Mergers & Acquisitions, Expansion Plans
    Table 34. Global Low Molecular Weight Heparin Sales by Type (2017-2022) & (MT)
    Table 35. Global Low Molecular Weight Heparin Sales by Type (2023-2028) & (MT)
    Table 36. Global Low Molecular Weight Heparin Sales Share by Type (2017-2022)
    Table 37. Global Low Molecular Weight Heparin Sales Share by Type (2023-2028)
    Table 38. Global Low Molecular Weight Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 39. Global Low Molecular Weight Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 40. Global Low Molecular Weight Heparin Revenue Share by Type (2017-2022)
    Table 41. Global Low Molecular Weight Heparin Revenue Share by Type (2023-2028)
    Table 42. Low Molecular Weight Heparin Price by Type (2017-2022) & (USD/MT)
    Table 43. Global Low Molecular Weight Heparin Price Forecast by Type (2023-2028) & (USD/MT)
    Table 44. Global Low Molecular Weight Heparin Sales by Application (2017-2022) & (MT)
    Table 45. Global Low Molecular Weight Heparin Sales by Application (2023-2028) & (MT)
    Table 46. Global Low Molecular Weight Heparin Sales Share by Application (2017-2022)
    Table 47. Global Low Molecular Weight Heparin Sales Share by Application (2023-2028)
    Table 48. Global Low Molecular Weight Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 49. Global Low Molecular Weight Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 50. Global Low Molecular Weight Heparin Revenue Share by Application (2017-2022)
    Table 51. Global Low Molecular Weight Heparin Revenue Share by Application (2023-2028)
    Table 52. Low Molecular Weight Heparin Price by Application (2017-2022) & (USD/MT)
    Table 53. Global Low Molecular Weight Heparin Price Forecast by Application (2023-2028) & (USD/MT)
    Table 54. North America Low Molecular Weight Heparin Sales by Type (2017-2022) & (MT)
    Table 55. North America Low Molecular Weight Heparin Sales by Type (2023-2028) & (MT)
    Table 56. North America Low Molecular Weight Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 57. North America Low Molecular Weight Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 58. North America Low Molecular Weight Heparin Sales by Application (2017-2022) & (MT)
    Table 59. North America Low Molecular Weight Heparin Sales by Application (2023-2028) & (MT)
    Table 60. North America Low Molecular Weight Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 61. North America Low Molecular Weight Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 62. North America Low Molecular Weight Heparin Sales by Country (2017-2022) & (MT)
    Table 63. North America Low Molecular Weight Heparin Sales by Country (2023-2028) & (MT)
    Table 64. North America Low Molecular Weight Heparin Revenue by Country (2017-2022) & (US$ Million)
    Table 65. North America Low Molecular Weight Heparin Revenue by Country (2023-2028) & (US$ Million)
    Table 66. Europe Low Molecular Weight Heparin Sales by Type (2017-2022) & (MT)
    Table 67. Europe Low Molecular Weight Heparin Sales by Type (2023-2028) & (MT)
    Table 68. Europe Low Molecular Weight Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 69. Europe Low Molecular Weight Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 70. Europe Low Molecular Weight Heparin Sales by Application (2017-2022) & (MT)
    Table 71. Europe Low Molecular Weight Heparin Sales by Application (2023-2028) & (MT)
    Table 72. Europe Low Molecular Weight Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 73. Europe Low Molecular Weight Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 74. Europe Low Molecular Weight Heparin Sales by Country (2017-2022) & (MT)
    Table 75. Europe Low Molecular Weight Heparin Sales by Country (2023-2028) & (MT)
    Table 76. Europe Low Molecular Weight Heparin Revenue by Country (2017-2022) & (US$ Million)
    Table 77. Europe Low Molecular Weight Heparin Revenue by Country (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Low Molecular Weight Heparin Sales by Type (2017-2022) & (MT)
    Table 79. Asia Pacific Low Molecular Weight Heparin Sales by Type (2023-2028) & (MT)
    Table 80. Asia Pacific Low Molecular Weight Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Low Molecular Weight Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 82. Asia Pacific Low Molecular Weight Heparin Sales by Application (2017-2022) & (MT)
    Table 83. Asia Pacific Low Molecular Weight Heparin Sales by Application (2023-2028) & (MT)
    Table 84. Asia Pacific Low Molecular Weight Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 85. Asia Pacific Low Molecular Weight Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 86. Asia Pacific Low Molecular Weight Heparin Sales by Region (2017-2022) & (MT)
    Table 87. Asia Pacific Low Molecular Weight Heparin Sales by Region (2023-2028) & (MT)
    Table 88. Asia Pacific Low Molecular Weight Heparin Revenue by Region (2017-2022) & (US$ Million)
    Table 89. Asia Pacific Low Molecular Weight Heparin Revenue by Region (2023-2028) & (US$ Million)
    Table 90. Latin America Low Molecular Weight Heparin Sales by Type (2017-2022) & (MT)
    Table 91. Latin America Low Molecular Weight Heparin Sales by Type (2023-2028) & (MT)
    Table 92. Latin America Low Molecular Weight Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 93. Latin America Low Molecular Weight Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 94. Latin America Low Molecular Weight Heparin Sales by Application (2017-2022) & (MT)
    Table 95. Latin America Low Molecular Weight Heparin Sales by Application (2023-2028) & (MT)
    Table 96. Latin America Low Molecular Weight Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 97. Latin America Low Molecular Weight Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 98. Latin America Low Molecular Weight Heparin Sales by Country (2017-2022) & (MT)
    Table 99. Latin America Low Molecular Weight Heparin Sales by Country (2023-2028) & (MT)
    Table 100. Latin America Low Molecular Weight Heparin Revenue by Country (2017-2022) & (US$ Million)
    Table 101. Latin America Low Molecular Weight Heparin Revenue by Country (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Low Molecular Weight Heparin Sales by Type (2017-2022) & (MT)
    Table 103. Middle East and Africa Low Molecular Weight Heparin Sales by Type (2023-2028) & (MT)
    Table 104. Middle East and Africa Low Molecular Weight Heparin Revenue by Type (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Low Molecular Weight Heparin Revenue by Type (2023-2028) & (US$ Million)
    Table 106. Middle East and Africa Low Molecular Weight Heparin Sales by Application (2017-2022) & (MT)
    Table 107. Middle East and Africa Low Molecular Weight Heparin Sales by Application (2023-2028) & (MT)
    Table 108. Middle East and Africa Low Molecular Weight Heparin Revenue by Application (2017-2022) & (US$ Million)
    Table 109. Middle East and Africa Low Molecular Weight Heparin Revenue by Application (2023-2028) & (US$ Million)
    Table 110. Middle East and Africa Low Molecular Weight Heparin Sales by Country (2017-2022) & (MT)
    Table 111. Middle East and Africa Low Molecular Weight Heparin Sales by Country (2023-2028) & (MT)
    Table 112. Middle East and Africa Low Molecular Weight Heparin Revenue by Country (2017-2022) & (US$ Million)
    Table 113. Middle East and Africa Low Molecular Weight Heparin Revenue by Country (2023-2028) & (US$ Million)
    Table 114. Aspen Corporation Information
    Table 115. Aspen Description and Major Businesses
    Table 116. Aspen Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 117. Aspen Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Aspen Recent Development
    Table 119. Sanofi-aventis Corporation Information
    Table 120. Sanofi-aventis Description and Major Businesses
    Table 121. Sanofi-aventis Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 122. Sanofi-aventis Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Sanofi-aventis Recent Development
    Table 124. Pfizer Corporation Information
    Table 125. Pfizer Description and Major Businesses
    Table 126. Pfizer Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 127. Pfizer Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Pfizer Recent Development
    Table 129. Opocrin Corporation Information
    Table 130. Opocrin Description and Major Businesses
    Table 131. Opocrin Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 132. Opocrin Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Opocrin Recent Development
    Table 134. CSBIO Corporation Information
    Table 135. CSBIO Description and Major Businesses
    Table 136. CSBIO Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 137. CSBIO Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. CSBIO Recent Development
    Table 139. Dongying Tiandong Pharmaceutical Corporation Information
    Table 140. Dongying Tiandong Pharmaceutical Description and Major Businesses
    Table 141. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 142. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Dongying Tiandong Pharmaceutical Recent Development
    Table 144. Changzhou Qianhong Bio-pharma Corporation Information
    Table 145. Changzhou Qianhong Bio-pharma Description and Major Businesses
    Table 146. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 147. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Changzhou Qianhong Bio-pharma Recent Development
    Table 149. Techdow Corporation Information
    Table 150. Techdow Description and Major Businesses
    Table 151. Techdow Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 152. Techdow Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Techdow Recent Development
    Table 154. Yantai Dongcheng Pharmaceutical Group Corporation Information
    Table 155. Yantai Dongcheng Pharmaceutical Group Description and Major Businesses
    Table 156. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 157. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Yantai Dongcheng Pharmaceutical Group Recent Development
    Table 159. Key Raw Materials Lists
    Table 160. Raw Materials Key Suppliers Lists
    Table 161. Low Molecular Weight Heparin Distributors List
    Table 162. Low Molecular Weight Heparin Customers List
    Table 163. Low Molecular Weight Heparin Market Trends
    Table 164. Low Molecular Weight Heparin Market Drivers
    Table 165. Low Molecular Weight Heparin Market Challenges
    Table 166. Low Molecular Weight Heparin Market Restraints
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Low Molecular Weight Heparin Product Picture
    Figure 2. Global Low Molecular Weight Heparin Market Share by Type in 2021 & 2028
    Figure 3. Enoxaparin Product Picture
    Figure 4. Dalteparin Product Picture
    Figure 5. Tinzaparin Product Picture
    Figure 6. Fraxiparine Product Picture
    Figure 7. Global Low Molecular Weight Heparin Market Share by Application in 2021 & 2028
    Figure 8. Treatment of Venous Thromboembolism
    Figure 9. Complications of Pregnancy
    Figure 10. Cardioversion of Atrial Fibrillation/Flutter
    Figure 11. Others
    Figure 12. Low Molecular Weight Heparin Report Years Considered
    Figure 13. Global Low Molecular Weight Heparin Capacity, Production and Utilization (2017-2028) & (MT)
    Figure 14. Global Low Molecular Weight Heparin Production Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Low Molecular Weight Heparin Production Market Share by Region (2017-2022)
    Figure 16. Global Low Molecular Weight Heparin Production Market Share by Region (2023-2028)
    Figure 17. Low Molecular Weight Heparin Production Growth Rate in North America (2017-2028) & (MT)
    Figure 18. Low Molecular Weight Heparin Production Growth Rate in Europe (2017-2028) & (MT)
    Figure 19. Low Molecular Weight Heparin Production Growth Rate in China (2017-2028) & (MT)
    Figure 20. Global Low Molecular Weight Heparin Sales 2017-2028 (MT)
    Figure 21. Global Low Molecular Weight Heparin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 22. Global Low Molecular Weight Heparin Revenue 2017-2028 (US$ Million)
    Figure 23. Global Low Molecular Weight Heparin Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 24. Global Low Molecular Weight Heparin Sales Market Share by Region (2017-2022)
    Figure 25. Global Low Molecular Weight Heparin Sales Market Share by Region (2023-2028)
    Figure 26. North America Low Molecular Weight Heparin Sales YoY (2017-2028) & (MT)
    Figure 27. North America Low Molecular Weight Heparin Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Low Molecular Weight Heparin Sales YoY (2017-2028) & (MT)
    Figure 29. Europe Low Molecular Weight Heparin Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Low Molecular Weight Heparin Sales YoY (2017-2028) & (MT)
    Figure 31. Asia-Pacific Low Molecular Weight Heparin Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. Latin America Low Molecular Weight Heparin Sales YoY (2017-2028) & (MT)
    Figure 33. Latin America Low Molecular Weight Heparin Revenue YoY (2017-2028) & (US$ Million)
    Figure 34. Middle East & Africa Low Molecular Weight Heparin Sales YoY (2017-2028) & (MT)
    Figure 35. Middle East & Africa Low Molecular Weight Heparin Revenue YoY (2017-2028) & (US$ Million)
    Figure 36. The Low Molecular Weight Heparin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 37. The Top 5 and 10 Largest Manufacturers of Low Molecular Weight Heparin in the World: Market Share by Low Molecular Weight Heparin Revenue in 2021
    Figure 38. Low Molecular Weight Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 39. Global Low Molecular Weight Heparin Sales Market Share by Type (2017-2028)
    Figure 40. Global Low Molecular Weight Heparin Revenue Market Share by Type (2017-2028)
    Figure 41. Global Low Molecular Weight Heparin Sales Market Share by Application (2017-2028)
    Figure 42. Global Low Molecular Weight Heparin Revenue Market Share by Application (2017-2028)
    Figure 43. North America Low Molecular Weight Heparin Sales Market Share by Type (2017-2028)
    Figure 44. North America Low Molecular Weight Heparin Revenue Market Share by Type (2017-2028)
    Figure 45. North America Low Molecular Weight Heparin Sales Market Share by Application (2017-2028)
    Figure 46. North America Low Molecular Weight Heparin Revenue Market Share by Application (2017-2028)
    Figure 47. North America Low Molecular Weight Heparin Sales Share by Country (2017-2028)
    Figure 48. North America Low Molecular Weight Heparin Revenue Share by Country (2017-2028)
    Figure 49. U.S. Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 50. Canada Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 51. Europe Low Molecular Weight Heparin Sales Market Share by Type (2017-2028)
    Figure 52. Europe Low Molecular Weight Heparin Revenue Market Share by Type (2017-2028)
    Figure 53. Europe Low Molecular Weight Heparin Sales Market Share by Application (2017-2028)
    Figure 54. Europe Low Molecular Weight Heparin Revenue Market Share by Application (2017-2028)
    Figure 55. Europe Low Molecular Weight Heparin Sales Share by Country (2017-2028)
    Figure 56. Europe Low Molecular Weight Heparin Revenue Share by Country (2017-2028)
    Figure 57. Germany Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 58. France Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 59. U.K. Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 60. Italy Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 61. Russia Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 62. Asia Pacific Low Molecular Weight Heparin Sales Market Share by Type (2017-2028)
    Figure 63. Asia Pacific Low Molecular Weight Heparin Revenue Market Share by Type (2017-2028)
    Figure 64. Asia Pacific Low Molecular Weight Heparin Sales Market Share by Application (2017-2028)
    Figure 65. Asia Pacific Low Molecular Weight Heparin Revenue Market Share by Application (2017-2028)
    Figure 66. Asia Pacific Low Molecular Weight Heparin Sales Share by Region (2017-2028)
    Figure 67. Asia Pacific Low Molecular Weight Heparin Revenue Share by Region (2017-2028)
    Figure 68. China Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 69. Japan Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 70. South Korea Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 71. India Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 72. Australia Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 73. China Taiwan Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 74. Indonesia Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 75. Thailand Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 76. Malaysia Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 77. Latin America Low Molecular Weight Heparin Sales Market Share by Type (2017-2028)
    Figure 78. Latin America Low Molecular Weight Heparin Revenue Market Share by Type (2017-2028)
    Figure 79. Latin America Low Molecular Weight Heparin Sales Market Share by Application (2017-2028)
    Figure 80. Latin America Low Molecular Weight Heparin Revenue Market Share by Application (2017-2028)
    Figure 81. Latin America Low Molecular Weight Heparin Sales Share by Country (2017-2028)
    Figure 82. Latin America Low Molecular Weight Heparin Revenue Share by Country (2017-2028)
    Figure 83. Mexico Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 84. Brazil Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 85. Argentina Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 86. Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Type (2017-2028)
    Figure 87. Middle East and Africa Low Molecular Weight Heparin Revenue Market Share by Type (2017-2028)
    Figure 88. Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Application (2017-2028)
    Figure 89. Middle East and Africa Low Molecular Weight Heparin Revenue Market Share by Application (2017-2028)
    Figure 90. Middle East and Africa Low Molecular Weight Heparin Sales Share by Country (2017-2028)
    Figure 91. Middle East and Africa Low Molecular Weight Heparin Revenue Share by Country (2017-2028)
    Figure 92. Turkey Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 93. Saudi Arabia Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 94. UAE Low Molecular Weight Heparin Revenue (2017-2028) & (US$ Million)
    Figure 95. Low Molecular Weight Heparin Value Chain
    Figure 96. Low Molecular Weight Heparin Production Process
    Figure 97. Channels of Distribution
    Figure 98. Distributors Profiles
    Figure 99. Bottom-up and Top-down Approaches for This Report
    Figure 100. Data Triangulation
    Figure 101. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Frequently Asked Questions
Low Molecular Weight Heparin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Low Molecular Weight Heparin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Low Molecular Weight Heparin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Electrical House

Electrical House market is segmented by players, region (country), by Type and by Application. Pl ... Read More

Mozzarella Cheese

Mozzarella Cheese market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

Xenon

Xenon market is segmented by Type and by Application. Players, stakeholders, and other participan ... Read More